Pharmacological characterization of MCCG and MAP4 at the mGluR1b, mGluR2 and mGluR4a human metabotropic glutamate receptor subtypes
- 31 August 1995
- journal article
- research article
- Published by Elsevier BV in Neuropharmacology
- Vol. 34 (8), 1099-1102
- https://doi.org/10.1016/0028-3908(95)00111-i
Abstract
No abstract availableKeywords
This publication has 14 references indexed in Scilit:
- Antagonism of the synaptic depressant actions of l-AP4 in the lateral perforant path by MAP4Neuropharmacology, 1995
- Molecular cloning, functional expression and pharmacological characterization of the human metabotropic glutamate receptor type 4Neuropharmacology, 1995
- Profiling of trans-azetidine-2,4-dicarboxylic acid at the human metabotropic glutamate receptors mGlu1b, -2, -4a and -5aEuropean Journal of Pharmacology: Molecular Pharmacology, 1995
- The metabotropic glutamate receptors: Structure and functionsNeuropharmacology, 1995
- Actions of phenylglycine analogs at subtypes of the metabotropic glutamate receptor familyEuropean Journal of Pharmacology: Molecular Pharmacology, 1994
- Stereospecific antagonism by (+)-α-methyl-4-carboxyphenylglycine (MCPG) of (1S,3R)-ACPD-induced effects in neonatal rat motoneurones and rat thalamic neuronesNeuropharmacology, 1993
- Induction of LTP in the hippocampus needs synaptic activation of glutamate metabotropic receptorsNature, 1993
- Competitive antagonism at metabotropic glutamate receptors by (S) -4-carboxyphenylglycine and (RS) -α-methyl-4-carboxyphenylglycineEuropean Journal of Pharmacology: Molecular Pharmacology, 1993
- Molecular Diversity of Glutamate Receptors and Implications for Brain FunctionScience, 1992
- Relationship between the inhibition constant (KI) and the concentration of inhibitor which causes 50 per cent inhibition (I50) of an enzymatic reactionBiochemical Pharmacology, 1973